Výsledky vyhledávání - "Karen L. Hoelzer"

Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study

Autor: Julie L. Ryan, Joseph A. Roscoe, Ann Dozier, Anita R. Peoples, Charlotte E. Coles, Michelle C. Janelsins, Charles E. Heckler, Karen L. Hoelzer, Karen M. Mustian, Luke J. Peppone, Gary R. Morrow, Dennis F. Moore, Robert C. Block

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 25(4)

Cancer-related fatigue (CRF) is a prevalent and distressing side effect of cancer and its treatment that remains inadequately understood and poorly managed. A better understanding of the factors contributing to CRF could result in more effective stra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f3613d7ee62dd670dfa947c706d15e
https://pubmed.ncbi.nlm.nih.gov/27995318

Zobrazit plný text záznamu

Insight in the Prediction of Chemotherapy-Induced Nausea

Autor: Andrew Jacobs, Joseph A. Roscoe, Gary R. Morrow, Charles E. Heckler, Bryan D. Pudlo, Lauren K. Colman, Karen L. Hoelzer, Ben Colagiuri

To identify risk factors for chemotherapy-related nausea. We examined risk factors for nausea in 1,696 patients from three multicenter studies conducted from 1998 to 2004. All patients were beginning a chemotherapy regimen containing cisplatin, carbo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f64fcbb7e670148450b038c1ed593a8
https://europepmc.org/articles/PMC3017350/

Zobrazit plný text záznamu

5-hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial

Autor: Christopher W. Bole, Tom R. Fitch, Jane T. Hickok, Karen L. Hoelzer, Gary R. Morrow, Hongwei Zhao, Joseph A. Roscoe, Shaker R. Dakhil, Timothy Moore

Summary Background Despite widespread use of short-acting antagonists for the 5-hydroxytryptamine (5-HT) receptor, about 50% of patients given moderately emetogenic chemotherapy have delayed nausea. We aimed to assess whether a 5-HT-receptor antagoni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca9dd3715f28e2ecb571b7c5c11fd40
https://europepmc.org/articles/PMC1646426/

Zobrazit plný text záznamu

Vinblastine-Associated Pulmonary Toxicity in Patients Receiving Combination Therapy with Mitomycin and Cisplatin

Autor: Dan W. Luedke, Karen L. Hoelzer, Susan W. Luedke, Bruce R. Harrison

Publikováno v: Drug Intelligence & Clinical Pharmacy. 20:287-289

Two of 33 patients entered in a local pilot study of mitomycin, vinblastine, and cisplatin for non-small cell lung cancer developed vinblastine-associated pulmonary toxicity. As with other reports of vinca alkaloid-related pulmonary toxicity, the reg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46b40edcc0dde1c241f4cce395197cb
https://doi.org/10.1177/106002808602000415

Zobrazit plný text záznamu

Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model

Autor: Gabriel N. Hortobagyi, Moshe Fridman, Edgardo Rivera, Chris A. Knight, M. Haim Erder, Timothy David Moore, Carol Brannan, Laurence Danel-Moore, Thomas L. Shiftan

Publikováno v: Cancer. 98(2)

AMF Consulting Incorporated, Los Angeles, Cal-ifornia.The authors thank William Carter, Ph.D., and theOncology Practice Pattern Study Group for provid-ing the historic-control database. MaryAnn Foote,Ph.D., assisted with the writing of this article.A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c451b48cce59e5e1d0eec375d751ea27
https://pubmed.ncbi.nlm.nih.gov/12872339

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání